Gamechanging new ovarian cancer drug niraparib (Zejula®) is now available for use in Northern Ireland. This is the first time that women with ovarian cancer in Northern Ireland will have access to the innovative new treatment that is already funded in England, Scotland and Wales. Target Ovarian Cancer played an important role in campaigning for […]